MHH Spin-off Cardior Raises EUR 15 Million
Cardior Pharmaceuticals has completed a EUR 15 million Series A financing round led by LSP (Life Sciences Partners), Boe…
Cardior Pharmaceuticals has completed a EUR 15 million Series A financing round led by LSP (Life Sciences Partners), Boe…
HepaRegeniX GmbH, a new Biotech company developing innovative treatments for liver diseases, announced today the complet…
HepaRegeniX GmbH, eine neue Biotechfirma, die innovative Behandlungen für Lebererkrankungen entwickelt, gab heute bekann…
On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scienti…
Am 6. Mai 2014 kamen Entscheidungsträger aus der Biopharma- und Medtech-Industrie in München mit führenden Wissenschaftl…
On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scienti…
Auf der Suche nach innovativen Projekten für ihre Entwicklungspipelines kamen zahlreiche Entscheidungsträger aus der bi…
BioVaria, Europe's leading marketplace for life-science inventions held on 4 June in Munich, attracted numerous decision…
On 4 June 2013 business developers and venture capitalists looking for cutting-edge life-science inventions will gather…
Am 4. Juni 2013 werden Investoren und Business Developer auf der Suche nach innovativen Life-Science Projekten zur 6. Bi…